Review of Current Strategies for Delivering Alzheimer’s Disease Drugs across the Blood-Brain Barrier
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review of Current Strategies for Delivering Alzheimer’s Disease Drugs across the Blood-Brain Barrier
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 2, Pages 381
Publisher
MDPI AG
Online
2019-01-18
DOI
10.3390/ijms20020381
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2018 Alzheimer's disease facts and figures
- (2018) Alzheimers & Dementia
- ABCA7 Downregulation Modifies Cellular Cholesterol Homeostasis and Decreases Amyloid-β Peptide Efflux in an in vitro Model of the Blood-Brain Barrier
- (2018) Yordenca Lamartinière et al. JOURNAL OF ALZHEIMERS DISEASE
- A nanoformulation for the preferential accumulation in adult neurogenic niches
- (2018) Catarina Praça et al. JOURNAL OF CONTROLLED RELEASE
- Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model
- (2018) Dario Carradori et al. Nanomedicine-Nanotechnology Biology and Medicine
- Blood–brain barrier opening in Alzheimer’s disease using MR-guided focused ultrasound
- (2018) Nir Lipsman et al. Nature Communications
- Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin
- (2017) Yung-Chih Kuo et al. International Journal of Nanomedicine
- New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9
- (2017) Elena Sánchez-López et al. Nanomedicine-Nanotechnology Biology and Medicine
- HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity
- (2017) Alina Hategan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Nanoparticles: Properties, applications and toxicities
- (2017) Ibrahim Khan et al. Arabian Journal of Chemistry
- HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity
- (2017) Alina Hategan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer’s disease mice
- (2017) Na Huang et al. Oncotarget
- Phytol-loaded PLGA nanoparticle as a modulator of Alzheimer’s toxic Aβ peptide aggregation and fibrillation associated with impaired neuronal cell function
- (2017) Sethuraman Sathya et al. Artificial Cells Nanomedicine and Biotechnology
- Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining
- (2017) Ming Zhang et al. PLoS One
- Non-invasive aerosol delivery and transport of gold nanoparticles to the brain
- (2017) Ramesh Raliya et al. Scientific Reports
- Brain imaging of neurovascular dysfunction in Alzheimer’s disease
- (2016) Axel Montagne et al. ACTA NEUROPATHOLOGICA
- A review on the biosynthesis of metallic nanoparticles (gold and silver) using bio-components of microalgae: Formation mechanism and applications
- (2016) P. Dheeban Shankar et al. ENZYME AND MICROBIAL TECHNOLOGY
- In vitro models of the blood–brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use
- (2016) Hans C Helms et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases
- (2016) Caroline Coisne et al. MOLECULES
- Transferrin-modified liposome promotes α-mangostin to penetrate the blood–brain barrier
- (2016) Zhi-Lan Chen et al. Nanomedicine-Nanotechnology Biology and Medicine
- Overview of Alzheimer’s Disease and Some Therapeutic Approaches Targeting Aβby Using Several Synthetic and Herbal Compounds
- (2016) Sandeep Kumar Singh et al. Oxidative Medicine and Cellular Longevity
- How Do the Size, Charge and Shape of Nanoparticles Affect Amyloid β Aggregation on Brain Lipid Bilayer?
- (2016) Yuna Kim et al. Scientific Reports
- Tackling amyloidogenesis in Alzheimer’s disease with A2V variants of Amyloid-β
- (2016) Giuseppe Di Fede et al. Scientific Reports
- Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
- (2015) Jason M. Lajoie et al. Annual Review of Pharmacology and Toxicology
- Drug-in-cyclodextrin-in-liposomes: A novel drug delivery system for flurbiprofen
- (2015) Lina Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Permeability of the Blood–Brain Barrier: Molecular Mechanism of Transport of Drugs and Physiologically Important Compounds
- (2015) Clifford W. Fong JOURNAL OF MEMBRANE BIOLOGY
- Galantamine-loaded PLGA nanoparticles, from nano-emulsion templating, as novel advanced drug delivery systems to treat neurodegenerative diseases
- (2015) C. Fornaguera et al. Nanoscale
- GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration
- (2015) Ethan A Winkler et al. NATURE NEUROSCIENCE
- Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer’s Disease
- (2015) Xiaoyao Zheng et al. PHARMACEUTICAL RESEARCH
- Anatomy and physiology of the blood–brain barrier
- (2015) Yonatan Serlin et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Intraperitoneal Administration of a Novel TAT-BDNF Peptide Ameliorates Cognitive Impairments via Modulating Multiple Pathways in Two Alzheimer’s Rodent Models
- (2015) Yuanyuan Wu et al. Scientific Reports
- Advances and Challenges of Liposome Assisted Drug Delivery
- (2015) Lisa Sercombe et al. Frontiers in Pharmacology
- β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease
- (2015) Xiaojuan Sun et al. Frontiers in Pharmacology
- Tau aggregation and its interplay with amyloid-β
- (2014) Rebecca M. Nisbet et al. ACTA NEUROPATHOLOGICA
- Cyclodextrins, Blood–Brain Barrier, and Treatment of Neurological Diseases
- (2014) Miklós Vecsernyés et al. ARCHIVES OF MEDICAL RESEARCH
- Protection of SK-N-MC cells against β-amyloid peptide-induced degeneration using neuron growth factor-loaded liposomes with surface lactoferrin
- (2014) Yung-Chih Kuo et al. BIOMATERIALS
- Gold-Nanoparticle-Based Multifunctional Amyloid-β Inhibitor against Alzheimer’s Disease
- (2014) Nan Gao et al. CHEMISTRY-A EUROPEAN JOURNAL
- Multifunctional nanoliposomes with curcumin–lipid derivative and brain targeting functionality with potential applications for Alzheimer disease
- (2014) Spyridon Mourtas et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Multifunctional Liposomes Reduce Brain -Amyloid Burden and Ameliorate Memory Impairment in Alzheimer's Disease Mouse Models
- (2014) C. Balducci et al. JOURNAL OF NEUROSCIENCE
- Neural compensation in older people with brain amyloid-β deposition
- (2014) Jeremy A Elman et al. NATURE NEUROSCIENCE
- Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
- (2014) Jeffrey L Cummings et al. Alzheimers Research & Therapy
- Curcumin-Loaded Nanoparticles Potently Induce Adult Neurogenesis and Reverse Cognitive Deficits in Alzheimer’s Disease Model via Canonical Wnt/β-Catenin Pathway
- (2013) Shashi Kant Tiwari et al. ACS Nano
- Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
- (2013) Fabien Gosselet et al. Current Alzheimer Research
- Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease
- (2013) Zhiyou Cai et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Changes in Brain Function Occur Years before the Onset of Cognitive Impairment
- (2013) L. L. Beason-Held et al. JOURNAL OF NEUROSCIENCE
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- (2013) Jean-Charles Lambert et al. NATURE GENETICS
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Mono and Dually Decorated Nanoliposomes for Brain Targeting, In Vitro and In Vivo Studies
- (2013) E. Markoutsa et al. PHARMACEUTICAL RESEARCH
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
- (2013) D. M. Holtzman et al. Cold Spring Harbor Perspectives in Medicine
- Liposome: classification, preparation, and applications
- (2013) Abolfazl Akbarzadeh et al. Nanoscale Research Letters
- Intranasal Administration of CNS Therapeutics to Awake Mice
- (2013) Leah R. Hanson et al. Jove-Journal of Visualized Experiments
- Amyloid β-Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression
- (2012) D. Allan Butterfield et al. ANTIOXIDANTS & REDOX SIGNALING
- β-Cyclodextrin-poly(β-Amino Ester) Nanoparticles for Sustained Drug Delivery across the Blood–Brain Barrier
- (2012) Eun Seok Gil et al. BIOMACROMOLECULES
- Hurdles with Using In Vitro Models to Predict Human Blood-brain Barrier Drug Permeability: A Special Focus on Transporters and Metabolizing Enzymes
- (2012) Ramzi Shawahna et al. CURRENT DRUG METABOLISM
- Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease
- (2012) Jiaqi Yao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease
- (2012) Anila Mathew et al. PLoS One
- A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys
- (2012) Sachiko Ohshima-Hosoyama et al. PLoS One
- Modern methods for delivery of drugs across the blood–brain barrier
- (2011) Yan Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
- (2011) Paola Milla et al. CURRENT DRUG METABOLISM
- New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations
- (2011) N. Başaran Mutlu et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Apolipoprotein E Regulates the Integrity of Tight Junctions in an Isoform-dependent Manner in anin VitroBlood-Brain Barrier Model
- (2011) Kazuchika Nishitsuji et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Focused ultrasound disruption of the blood-brain barrier: a new frontier for therapeutic delivery in molecular neurooncology
- (2011) Arnold B. Etame et al. Neurosurgical Focus
- A Peptide That Binds Specifically to the β-Amyloid of Alzheimer's Disease: Selection and Assessment of Anti-β-Amyloid Neurotoxic Effects
- (2011) Fang Wang et al. PLoS One
- Minimally invasive molecular delivery into the brain using optical modulation of vascular permeability
- (2011) M. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
- (2011) Hirenkumar K. Makadia et al. Polymers
- Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery
- (2010) Huali Chen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Strategy for effective brain drug delivery
- (2010) M. Intakhab Alam et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Calcium Signaling and Amyloid Toxicity in Alzheimer Disease
- (2010) Angelo Demuro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy private milieus: The former opens to the portal blood and the latter to the cerebrospinal fluid
- (2010) Esteban M. Rodríguez et al. PEPTIDES
- In Vivo Methods to Study Uptake of Nanoparticles into the Brain
- (2010) Inge van Rooy et al. PHARMACEUTICAL RESEARCH
- RETRACTED: Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo
- (2009) Preetha Anand et al. BIOCHEMICAL PHARMACOLOGY
- IgG-single chain Fv fusion protein therapeutic for alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkey
- (2009) Ruben J. Boado et al. BIOTECHNOLOGY AND BIOENGINEERING
- Characteristics of compounds that cross the blood-brain barrier
- (2009) William A Banks BMC Neurology
- Lactoferrin as a Natural Immune Modulator
- (2009) Jeffrey Actor et al. CURRENT PHARMACEUTICAL DESIGN
- The role of tau in neurodegeneration
- (2009) Tania F Gendron et al. Molecular Neurodegeneration
- Structure and function of the blood–brain barrier
- (2009) N. Joan Abbott et al. NEUROBIOLOGY OF DISEASE
- Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
- (2008) C.-X. Gong et al. CURRENT MEDICINAL CHEMISTRY
- The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
- (2008) Berislav V. Zlokovic NEURON
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease
- (2008) P. Hemachandra Reddy et al. TRENDS IN MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started